NCT03600883 · Interventional trial
A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100)
Overall registry status Completed
Phase 1 · Phase 2
Conditions KRAS p.G12C Mutant Advanced Solid Tumors
Delaware Valley sites
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County
- University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory